carbapenems has been researched along with Fasciitis, Necrotizing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YH; Cheng, NC; Cheng, Y; Chien, KL; Fang, CT; Hsueh, PR; Tai, HC; Wang, SH | 1 |
| Naser, N; Shliapnikov, SA | 1 |
1 review(s) available for carbapenems and Fasciitis, Necrotizing
| Article | Year |
|---|---|
[Surgical infection of soft tissue--a problem of adequate antibiotic therapy].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Diabetic Foot; Drug Therapy, Combination; Fasciitis, Necrotizing; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Soft Tissue Infections; Species Specificity; Surgical Wound Infection | 2003 |
1 other study(ies) available for carbapenems and Fasciitis, Necrotizing
| Article | Year |
|---|---|
High mortality risk of type III monomicrobial gram-negative necrotizing fasciitis: The role of extraintestinal pathogenic Escherichia coli (ExPEC) and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fasciitis, Necrotizing; Humans; Klebsiella pneumoniae; Streptococcal Infections | 2023 |